Tag: neuropathic pain
Nalu Medical closes US$85 million Series E financing round
Nalu Medical has announced the closing of an incremental US$20 million in equity financing from new investor B Capital, bringing its total Series E...
Neuralace announces upcoming SEAT trial presentation among other clinical milestones
Neuralace Medical has announced the upcoming clinical study presentation of the SEAT randomised controlled trial (RCT), which is assessing the safety and efficacy of...
Millimetric implant offers promising alternative to opioids or surgery in pain...
Using a one-millimetre-sized wireless implant to stimulate peripheral nerves from within blood vessels has the potential to treat neuropathic pain that is resistant to...
Recommended use of SCS in neuropathic pain has not led to...
Only a small proportion of neuropathic pain patients in England who are potentially eligible for spinal cord stimulation (SCS) have received this intervention over...
NeuraLace announces two new patents for Axon neuropathic pain therapies
NeuraLace Medical has announced the expansion of its global patent portfolio with the issuance of two new patents: US Patent No. 11,305,130 for "Devices, systems,...
Lower frequencies may improve outcomes of pain treatment with dorsal root...
Lower frequencies of dorsal root ganglion stimulation (DRG-S) may be more effective in the treatment of neuropathic pain—as per a late-breaking presentation from Guilherme...
